Mtor inhibitors are a class of targeted therapeutic agents designed to block the mammalian target of rapamycin (mTOR) pathway, a key regulator of cell growth, proliferation, metabolism, and angiogenesis. Widely used in oncology, renal transplantation, and rare genetic disorders such as tuberous sclerosis complex, these inhibitors offer significant advantages over traditional cytotoxic... https://www.patreon.com/posts/mtor-inhibitors-127797270?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link